Margenza Injection, Solution, Concentrate
Product Images NDC 74527-022

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Margenza (NDC 74527-022). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Macrogenics, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Margenza 01)

FDA Label Image

Principal Display Panel (250 mg/10 mL Vial Carton)

Principal Display Panel (250 mg/10 mL Vial Carton)
This is a description for Margenza® injection. It is a single-dose vial containing 250mg/10ml (25mg/ml) of Margituximab-cmkt which is used for intravenous infusion after dilution. It is recommended to be stored in a refrigerated environment and not shaken. It is also advised to discard unused portions. The text includes information on the contents of the injection and directions for usage.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.